These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 23278838

  • 21. Could Immunoglobulin Level Be a Prognostic Factor for Coronary Artery Lesions in Kawasaki Diseases?
    Han MY.
    Korean Circ J; 2021 Mar; 51(3):279-280. PubMed ID: 33655728
    [No Abstract] [Full Text] [Related]

  • 22. Retracted: Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease.
    Healthcare Engineering JO.
    J Healthc Eng; 2023 Mar; 2023():9824018. PubMed ID: 37799651
    [Abstract] [Full Text] [Related]

  • 23. Optimizing the speed of intravenous immunoglobulin infusion for Kawasaki Disease.
    Chin CY.
    Pediatr Neonatol; 2024 Aug 06. PubMed ID: 39122627
    [No Abstract] [Full Text] [Related]

  • 24. Index of suspicion. Case 1. Diagnosis: Kawasaki Disease.
    Torchinsky MY, Landau D.
    Pediatr Rev; 2000 Jan 06; 21(1):20-23. PubMed ID: 10617759
    [No Abstract] [Full Text] [Related]

  • 25. Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience.
    Skochko SM, Jain S, Sun X, Sivilay N, Kanegaye JT, Pancheri J, Shimizu C, Sheets R, Tremoulet AH, Burns JC.
    J Pediatr; 2018 Dec 06; 203():408-415.e3. PubMed ID: 30268398
    [Abstract] [Full Text] [Related]

  • 26. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
    J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
    [Abstract] [Full Text] [Related]

  • 27. Coronary Artery Outcomes in Kawasaki Disease by Treatment Day Within 10 Days of Fever Onset.
    Karandikar VM, Khan H, Kim KA, Kociolek LK, Jhaveri R, Shulman ST, Rowley AH.
    Open Forum Infect Dis; 2024 Jul 15; 11(7):ofae352. PubMed ID: 38994442
    [Abstract] [Full Text] [Related]

  • 28. Kawasaki disease, autoimmune disorders, and cancer: a register-based study.
    Nielsen TM, Andersen NH, Torp-Pedersen C, Søgaard P, Kragholm KH.
    Eur J Pediatr; 2021 Mar 15; 180(3):717-723. PubMed ID: 32772155
    [Abstract] [Full Text] [Related]

  • 29. Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis.
    Yan F, Pan B, Sun H, Tian J, Li M.
    Front Pediatr; 2019 Mar 15; 7():374. PubMed ID: 31612117
    [Abstract] [Full Text] [Related]

  • 30. Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne.
    de La Harpe M, di Bernardo S, Hofer M, Sekarski N.
    Front Pediatr; 2019 Mar 15; 7():11. PubMed ID: 30761279
    [Abstract] [Full Text] [Related]

  • 31. Safety netting versus overtreatment in paediatrics: viral infection or incomplete Kawasaki disease?
    Charlesworth JM, Power B, Moylett E.
    BMJ Case Rep; 2017 Nov 08; 2017():. PubMed ID: 29122906
    [Abstract] [Full Text] [Related]

  • 32. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.
    Okubo Y, Nochioka K, Sakakibara H, Testa M, Sundel RP.
    Clin Rheumatol; 2017 Feb 08; 36(2):413-419. PubMed ID: 27987089
    [Abstract] [Full Text] [Related]

  • 33. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G.
    Rheumatol Int; 2015 Jun 08; 35(6):1053-8. PubMed ID: 25429794
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
    Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED.
    Acta Paediatr; 2013 Apr 08; 102(4):385-90. PubMed ID: 23278838
    [Abstract] [Full Text] [Related]

  • 35. Kawasaki syndrome and factors associated with coronary artery abnormalities in California.
    Callinan LS, Tabnak F, Holman RC, Maddox RA, Kim JJ, Schonberger LB, Vugia DJ, Belay ED.
    Pediatr Infect Dis J; 2012 Sep 08; 31(9):894-8. PubMed ID: 22565293
    [Abstract] [Full Text] [Related]

  • 36. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.
    Singh-Grewal D, Wong M, Isaacs D.
    J Paediatr Child Health; 2005 Sep 08; 41(9-10):495-9. PubMed ID: 16150066
    [Abstract] [Full Text] [Related]

  • 37. Characteristics of Kawasaki disease in older children.
    Cai Z, Zuo R, Liu Y.
    Clin Pediatr (Phila); 2011 Oct 08; 50(10):952-6. PubMed ID: 21628347
    [Abstract] [Full Text] [Related]

  • 38. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T, Inoue Y, Morikawa A.
    Nihon Rinsho; 2008 Feb 08; 66(2):332-7. PubMed ID: 18260333
    [Abstract] [Full Text] [Related]

  • 39. Kawasaki disease: part II. Complications and treatment.
    Bayers S, Shulman ST, Paller AS.
    J Am Acad Dermatol; 2013 Oct 08; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
    Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED.
    Acta Paediatr; 2013 Apr 08; 102(4):385-90. PubMed ID: 23278838
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.